カテゴリー： Market Monitor Global, 世界, 医療/バイオ

パシレオチド薬の世界市場見通し2023年-2029年

◆英語タイトル：Pasireotide Drugs Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5877）

◆商品コード：MMG23JU5877
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：77
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Pasireotide Drugs Market 調査レポートは次の情報を含め、グローバルにおけるのパシレオチド薬市場規模と予測を収録しています。・世界のパシレオチド薬市場：売上、2018年-2023年、2024年-2029年
・世界のパシレオチド薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のパシレオチド薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「0.3mg/ml」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

パシレオチド薬のグローバル主要企業は、Novartisなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、パシレオチド薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のパシレオチド薬市場：タイプ別、2018年-2023年、2024年-2029年
世界のパシレオチド薬市場：タイプ別市場シェア、2022年
・0.3mg/ml、0.6mg/ml、0.9mg/ml

世界のパシレオチド薬市場：用途別、2018年-2023年、2024年-2029年
世界のパシレオチド薬市場：用途別市場シェア、2022年
・病院、薬局

世界のパシレオチド薬市場：地域・国別、2018年-2023年、2024年-2029年
世界のパシレオチド薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるパシレオチド薬のグローバル売上、2018年-2023年
・主要企業におけるパシレオチド薬のグローバル売上シェア、2022年
・主要企業におけるパシレオチド薬のグローバル販売量、2018年-2023年
・主要企業におけるパシレオチド薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Novartis

*************************************************************

・調査・分析レポートの概要
パシレオチド薬市場の定義
市場セグメント
世界のパシレオチド薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のパシレオチド薬市場規模
世界のパシレオチド薬市場規模：2022年 VS 2029年
世界のパシレオチド薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのパシレオチド薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のパシレオチド薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：0.3mg/ml、0.6mg/ml、0.9mg/ml
パシレオチド薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、薬局
パシレオチド薬の用途別グローバル売上・予測

・地域別市場分析
地域別パシレオチド薬市場規模 2022年と2029年
地域別パシレオチド薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Novartis
...

Pasireotide is an orphan drug approved in the United States and Europe for the treatment of Cushing’s disease in patients who fail or are ineligible for surgical therapy.
This report aims to provide a comprehensive presentation of the global market for Pasireotide Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pasireotide Drugs. This report contains market size and forecasts of Pasireotide Drugs in global, including the following market information:
Global Pasireotide Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Pasireotide Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Pasireotide Drugs companies in 2022 (%)
The global Pasireotide Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
0.3mg/ml Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Pasireotide Drugs include Novartis. etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pasireotide Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pasireotide Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Pasireotide Drugs Market Segment Percentages, by Type, 2022 (%)
0.3mg/ml
0.6mg/ml
0.9mg/ml
Global Pasireotide Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Pasireotide Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital
Pharmacy
Global Pasireotide Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Pasireotide Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pasireotide Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Pasireotide Drugs revenues share in global market, 2022 (%)
Key companies Pasireotide Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Pasireotide Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pasireotide Drugs, market overview.
Chapter 2: Global Pasireotide Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Pasireotide Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pasireotide Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Pasireotide Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Pasireotide Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pasireotide Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pasireotide Drugs Overall Market Size
2.1 Global Pasireotide Drugs Market Size: 2022 VS 2029
2.2 Global Pasireotide Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Pasireotide Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Pasireotide Drugs Players in Global Market
3.2 Top Global Pasireotide Drugs Companies Ranked by Revenue
3.3 Global Pasireotide Drugs Revenue by Companies
3.4 Global Pasireotide Drugs Sales by Companies
3.5 Global Pasireotide Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Pasireotide Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Pasireotide Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Pasireotide Drugs Players in Global Market
3.8.1 List of Global Tier 1 Pasireotide Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Pasireotide Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Pasireotide Drugs Market Size Markets, 2022 & 2029
4.1.2 0.3mg/ml
4.1.3 0.6mg/ml
4.1.4 0.9mg/ml
4.2 By Type – Global Pasireotide Drugs Revenue & Forecasts
4.2.1 By Type – Global Pasireotide Drugs Revenue, 2018-2023
4.2.2 By Type – Global Pasireotide Drugs Revenue, 2024-2029
4.2.3 By Type – Global Pasireotide Drugs Revenue Market Share, 2018-2029
4.3 By Type – Global Pasireotide Drugs Sales & Forecasts
4.3.1 By Type – Global Pasireotide Drugs Sales, 2018-2023
4.3.2 By Type – Global Pasireotide Drugs Sales, 2024-2029
4.3.3 By Type – Global Pasireotide Drugs Sales Market Share, 2018-2029
4.4 By Type – Global Pasireotide Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Pasireotide Drugs Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Pharmacy
5.2 By Application – Global Pasireotide Drugs Revenue & Forecasts
5.2.1 By Application – Global Pasireotide Drugs Revenue, 2018-2023
5.2.2 By Application – Global Pasireotide Drugs Revenue, 2024-2029
5.2.3 By Application – Global Pasireotide Drugs Revenue Market Share, 2018-2029
5.3 By Application – Global Pasireotide Drugs Sales & Forecasts
5.3.1 By Application – Global Pasireotide Drugs Sales, 2018-2023
5.3.2 By Application – Global Pasireotide Drugs Sales, 2024-2029
5.3.3 By Application – Global Pasireotide Drugs Sales Market Share, 2018-2029
5.4 By Application – Global Pasireotide Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Pasireotide Drugs Market Size, 2022 & 2029
6.2 By Region – Global Pasireotide Drugs Revenue & Forecasts
6.2.1 By Region – Global Pasireotide Drugs Revenue, 2018-2023
6.2.2 By Region – Global Pasireotide Drugs Revenue, 2024-2029
6.2.3 By Region – Global Pasireotide Drugs Revenue Market Share, 2018-2029
6.3 By Region – Global Pasireotide Drugs Sales & Forecasts
6.3.1 By Region – Global Pasireotide Drugs Sales, 2018-2023
6.3.2 By Region – Global Pasireotide Drugs Sales, 2024-2029
6.3.3 By Region – Global Pasireotide Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Pasireotide Drugs Revenue, 2018-2029
6.4.2 By Country – North America Pasireotide Drugs Sales, 2018-2029
6.4.3 US Pasireotide Drugs Market Size, 2018-2029
6.4.4 Canada Pasireotide Drugs Market Size, 2018-2029
6.4.5 Mexico Pasireotide Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Pasireotide Drugs Revenue, 2018-2029
6.5.2 By Country – Europe Pasireotide Drugs Sales, 2018-2029
6.5.3 Germany Pasireotide Drugs Market Size, 2018-2029
6.5.4 France Pasireotide Drugs Market Size, 2018-2029
6.5.5 U.K. Pasireotide Drugs Market Size, 2018-2029
6.5.6 Italy Pasireotide Drugs Market Size, 2018-2029
6.5.7 Russia Pasireotide Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Pasireotide Drugs Market Size, 2018-2029
6.5.9 Benelux Pasireotide Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Pasireotide Drugs Revenue, 2018-2029
6.6.2 By Region – Asia Pasireotide Drugs Sales, 2018-2029
6.6.3 China Pasireotide Drugs Market Size, 2018-2029
6.6.4 Japan Pasireotide Drugs Market Size, 2018-2029
6.6.5 South Korea Pasireotide Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Pasireotide Drugs Market Size, 2018-2029
6.6.7 India Pasireotide Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Pasireotide Drugs Revenue, 2018-2029
6.7.2 By Country – South America Pasireotide Drugs Sales, 2018-2029
6.7.3 Brazil Pasireotide Drugs Market Size, 2018-2029
6.7.4 Argentina Pasireotide Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Pasireotide Drugs Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Pasireotide Drugs Sales, 2018-2029
6.8.3 Turkey Pasireotide Drugs Market Size, 2018-2029
6.8.4 Israel Pasireotide Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Pasireotide Drugs Market Size, 2018-2029
6.8.6 UAE Pasireotide Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Pasireotide Drugs Major Product Offerings
7.1.4 Novartis Pasireotide Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Novartis Key News & Latest Developments
8 Global Pasireotide Drugs Production Capacity, Analysis
8.1 Global Pasireotide Drugs Production Capacity, 2018-2029
8.2 Pasireotide Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Pasireotide Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Pasireotide Drugs Supply Chain Analysis
10.1 Pasireotide Drugs Industry Value Chain
10.2 Pasireotide Drugs Upstream Market
10.3 Pasireotide Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Pasireotide Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Pasireotide Drugs in Global Market
Table 2. Top Pasireotide Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Pasireotide Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Pasireotide Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Pasireotide Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Pasireotide Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Pasireotide Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Pasireotide Drugs Product Type
Table 9. List of Global Tier 1 Pasireotide Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pasireotide Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Pasireotide Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Pasireotide Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Pasireotide Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Pasireotide Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Pasireotide Drugs Sales (K Units), 2024-2029
Table 16. By Application – Global Pasireotide Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Pasireotide Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Pasireotide Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Pasireotide Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Pasireotide Drugs Sales (K Units), 2024-2029
Table 21. By Region – Global Pasireotide Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Pasireotide Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Pasireotide Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Pasireotide Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Pasireotide Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America Pasireotide Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Pasireotide Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Pasireotide Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Pasireotide Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe Pasireotide Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Pasireotide Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Pasireotide Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Pasireotide Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia Pasireotide Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Pasireotide Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Pasireotide Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Pasireotide Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America Pasireotide Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Pasireotide Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Pasireotide Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Pasireotide Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Pasireotide Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Pasireotide Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Pasireotide Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Pasireotide Drugs Sales, (K Units), 2024-2029
Table 46. Novartis Company Summary
Table 47. Novartis Pasireotide Drugs Product Offerings
Table 48. Novartis Pasireotide Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Novartis Key News & Latest Developments
Table 50. Pasireotide Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 51. Global Pasireotide Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 52. Global Pasireotide Drugs Production by Region, 2018-2023 (K Units)
Table 53. Global Pasireotide Drugs Production by Region, 2024-2029 (K Units)
Table 54. Pasireotide Drugs Market Opportunities & Trends in Global Market
Table 55. Pasireotide Drugs Market Drivers in Global Market
Table 56. Pasireotide Drugs Market Restraints in Global Market
Table 57. Pasireotide Drugs Raw Materials
Table 58. Pasireotide Drugs Raw Materials Suppliers in Global Market
Table 59. Typical Pasireotide Drugs Downstream
Table 60. Pasireotide Drugs Downstream Clients in Global Market
Table 61. Pasireotide Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Pasireotide Drugs Segment by Type in 2022
Figure 2. Pasireotide Drugs Segment by Application in 2022
Figure 3. Global Pasireotide Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Pasireotide Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Pasireotide Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Pasireotide Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Pasireotide Drugs Revenue in 2022
Figure 9. By Type - Global Pasireotide Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Pasireotide Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Pasireotide Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Pasireotide Drugs Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Pasireotide Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Pasireotide Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Pasireotide Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Pasireotide Drugs Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Pasireotide Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Pasireotide Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Pasireotide Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Pasireotide Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Pasireotide Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Pasireotide Drugs Sales Market Share, 2018-2029
Figure 23. US Pasireotide Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Pasireotide Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Pasireotide Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Pasireotide Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Pasireotide Drugs Sales Market Share, 2018-2029
Figure 28. Germany Pasireotide Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Pasireotide Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Pasireotide Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Pasireotide Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Pasireotide Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Pasireotide Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Pasireotide Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Pasireotide Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Pasireotide Drugs Sales Market Share, 2018-2029
Figure 37. China Pasireotide Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Pasireotide Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Pasireotide Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Pasireotide Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Pasireotide Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Pasireotide Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Pasireotide Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Pasireotide Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Pasireotide Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Pasireotide Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Pasireotide Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Pasireotide Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Pasireotide Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Pasireotide Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Pasireotide Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Pasireotide Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Pasireotide Drugs by Region, 2022 VS 2029
Figure 54. Pasireotide Drugs Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ パシレオチド薬の世界市場見通し2023年-2029年(Pasireotide Drugs Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

パシレオチド薬の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp